CME Symposium on Cardiovascular Risk Reduction and LDL-C: Evolving Perspectives
This CME Symposium takes place on Thursday, April 5, 2018 from 8:00 AM - 9:00 AM at the Baltimore Marriott Waterfront Hotel in Baltimore, Maryland.
Robert P. Giugliano, MD, SM
Associate Professor of Medicine
Harvard Medical School
Pamela Morris, MD
Cedars-Sinai Heart Institute
Los Angeles, CA
Click to Register Online
Cardiovascular nurses play a critical role in managing patients with increased atherosclerotic cardiovascular disease (ASCVD) risk, and specifically, in patients with elevated LDL-Cholesterol (LDL-C). Their efforts at reducing ASCVD risk in patients with elevated LDL-C should be based on guideline-recommended use of statin therapy, up-to-date knowledge on clinical profiles of non-statin drugs, and awareness and implementation of updated pathways for the use of non-statin therapies for LDL-C lowering. In addition, through effective communication, patient education, and shared decision-making, cardiovascular nurses can create activated, adherent patients. This educational initiative will explore, through state-of-the-
This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). Multiple educational grants have been requested to support this program. PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602. This program is accredited for 1 contact hour of continuing education. This program was planned in accordance with AANP CE Policies and Commercial Support Standards.
This activity is supported by an educational donation provided by Amgen.
Pre-registration is for planning purposes only.
For additional CME activities and online CME courses, visit CMEPlanet.
Page Updated Last on: Mar 22, 2018